Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Isnardi

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Arthritis & Rheumatology (Hoboken, N.J.)|January 17, 2020
Requirement of Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1 Protease Activity for Fcγ Receptor-Induced Arthritis, but Not Fcγ Receptor-Mediated Platelet Elimination, in MiceKea Martin, Ratiba Touil, Grozdan Cvijetic, et al.
Molecular Cancer Therapeutics|August 28, 2020
Development of Anti-CD32b Antibodies with Enhanced Fc Function for the Treatment of B and Plasma Cell MalignanciesHaihui Lu, Ryan D Molony, Dongshu Chen, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Arthritis & Rheumatology (Hoboken, N.J.)|January 17, 2020
Requirement of Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1 Protease Activity for Fcγ Receptor-Induced Arthritis, but Not Fcγ Receptor-Mediated Platelet Elimination, in MiceKea Martin, Ratiba Touil, Grozdan Cvijetic, et al.
Molecular Cancer Therapeutics|August 28, 2020
Development of Anti-CD32b Antibodies with Enhanced Fc Function for the Treatment of B and Plasma Cell MalignanciesHaihui Lu, Ryan D Molony, Dongshu Chen, et al.
Pageof 2